Related Experiment Videos
Liquid ventilation of human preterm neonates.
J S Greenspan1, M R Wolfson, S D Rubenstein
1Department of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania.
The Journal of Pediatrics
|July 1, 1990
Summary
Investigational liquid perfluorochemical ventilation showed feasibility in preterm neonates with severe respiratory distress. While lung function improved, all infants died within 19 hours, likely due to underlying disease severity.
Area of Science:
- Neonatal Medicine
- Respiratory Physiology
- Experimental Therapeutics
Background:
- Severe respiratory distress is a critical condition in preterm neonates.
- Conventional therapies often fail in the most severe cases.
- Investigational treatments are needed for refractory neonatal respiratory failure.
Purpose of the Study:
- To assess the feasibility and initial outcomes of liquid perfluorochemical ventilation.
- To evaluate the effects of liquid ventilation on lung mechanics and oxygenation in preterm neonates.
- To explore a novel therapeutic approach for severe pulmonary dysfunction in extremely premature infants.
Main Methods:
- Liquid ventilation using perfluorochemicals was administered to three preterm neonates.
- The technique involved gravity-assisted, short-duration cycles.
- Conventional therapies had previously failed in all participants.
Main Results:
- Liquid ventilation was performed without procedural difficulty.
- All infants demonstrated improved lung distensibility post-procedure.
- Oxygenation improved in two of the three neonates.
- No perfluorochemical fluid was found retained in the lungs or pleural space post-mortem.
Conclusions:
- Liquid perfluorochemical ventilation is a feasible investigational therapy for preterm neonates.
- The procedure showed potential for improving lung function in severe respiratory distress.
- Infant mortality was attributed to the pre-existing severity of lung disease, not the liquid ventilation itself.